know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

ENDO 2026 Abstract Submission Now Open

November 18, 2025

You may now submit your abstract for presentation at ENDO 2026. Share your research at the premier annual meeting in endocrinology, taking place June 13-16, 2026, in Chicago, IL, USA. Submitting an abstract earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive patient care for the people that need us most.

Membership

Invest in Yourself

November 18, 2025

Renew your membership by Wednesday, December 31 to keep your exclusive resources, including access to our global network, top-ranked journals, and discounts to our annual meeting, ENDO. Elevate your career with premier, yearlong, professional development resources. We look forward to partnering with you in another year of growth, opportunity, and career advancement. Renew today!

Store

Just Dropped: New Gifts for Endocrinologists

November 19, 2025

Exciting news! Our store has all-new items for clinicians. From stylish apparel to exclusive gifts, these pieces celebrate the field of endocrinology with quality, professionalism, and flair. Discover what's new and shop today.

Awards

REGMS Applications Are Now Being Accepted

October 28, 2025

Gain hands-on experience in endocrine research through the Endocrine Society’s Research Experiences for Graduate and Medical Students (REGMS) program. Participants conduct a mentored summer project, join career-development webinars, and present their work during ENDO 2027. Awarded applicants receive a $2,500 honorarium and a $1,500 travel grant.

Advocacy

Advocacy in Action

November 14, 2025

Our Advocacy in Action includes details on the NIH's outlook after the end of the government shutdown; our campaign to urge Congress to reauthorize the Special Diabetes Program; the FDA's move to remove “Black Box” warnings from hormone replacement therapy products for menopause, CMS's expanded Medicare coverage of anti-obesity medications over the next two years, and the Society's full analysis of Medicare Physician Payment Rule for CY 2026.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Webinar will discuss pill formulations of GLP-1s

November 13, 2025

Endocrine Society experts will discuss the next evolution of anti-obesity medications, including the first pill formulations of GLP-1s, during a Virtual Science Writers Conference on December 10.

Strong grip strength may protect against obesity-related complications

October 15, 2025

People with excess body fat who build and keep muscle may be less likely to develop obesity-induced heart, liver, or kidney damage or die early, according to a new study published in The Journal of Clinical Endocrinology & Metabolism.

GLP-1s show promise in treating alcohol and drug addiction

October 09, 2025

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine Society.

View More

Featured Journal Articles

Diagnostic Journey in the Recognition of Oncogenic Osteomalacia

November 18, 2025

The authors report a 73-year-old woman with a remote history of successfully treated primary hyperparathyroidism who was referred for evaluation of multiple skeletal fractures and proximal muscle weakness.

Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease

November 18, 2025

This study investigates the association between biomarkers and hepatic steatosis and stiffness measurements, measured by FibroScan®.

Evaluating the Total Healthcare Cost of Inappropriately Ordered Thyroid Ultrasounds

November 18, 2025

This study evaluated the healthcare cost of inappropriately ordered thyroid ultrasound in a national multicenter academic system.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.